Medicine Description uromess 400mg
Uromess 400 mg Injection is a medication that primarily functions as a uroprotective agent. Its active ingredient, mesna, works by binding to toxic metabolites of certain chemotherapy drugs, particularly ifosfamide and cyclophosphamide. These metabolites can cause irritation and damage to the bladder's urothelium, leading to hemorrhagic cystitis. Mesna neutralizes these harmful metabolites in the urine, thereby preventing their interaction with the bladder lining. This mechanism significantly reduces the risk of bladder toxicity, enabling patients to undergo necessary chemotherapy treatments with enhanced safety and comfort.
Indications and Uses of Uromess 400 mg Injection
- Prevention of hemorrhagic cystitis induced by ifosfamide and cyclophosphamide chemotherapy
- Protection of the bladder from potential damage resulting from certain cytotoxic agents
- Part of supportive care in patients receiving specific chemotherapy regimens
Side Effects of Uromess 400 mg Injection
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headaches
- Allergic reactions, including rash or itching
Storage and Handling
Uromess 400 mg Injection should be stored at room temperature, away from direct sunlight and moisture. It must be kept out of reach of children and disposed of properly if expired or no longer needed.
Patient Advice and Precautions
Patients receiving Uromess should maintain adequate hydration to facilitate the excretion of toxic metabolites. It is crucial to follow the healthcare provider's instructions closely and report any unusual symptoms or side effects experienced during treatment. Regular monitoring of bladder function may be advised, especially in patients with pre-existing urinary conditions.